During the past decade, Oaklawn Physicians Group conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Oaklawn Physicians Group" are "HIV Infections" (10 trials), "Cytomegalovirus Infections" (1 trials) and "Cytomegalovirus Retinitis" (1 trials). Many other conditions were trialed in "Oaklawn Physicians Group" in a lesser frequency.

Most popular intervention types in "Oaklawn Physicians Group" are "Drug" (10 trials). Other intervention types were less common.

The name of intervention was led by "Nelfinavir mesylate" (4 trials), "Stavudine" (4 trials), "Atazanavir" (2 trials), "Didanosine" (2 trials) and "Efavirenz" (2 trials). Other intervention names were less common.

The vast majority of trials in "Oaklawn Physicians Group" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Oaklawn Physicians Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Oaklawn Physicians Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oaklawn Physicians Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".